Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 173


A Budget Impact Model of Hemophilia Bypassing Agent Prophylaxis Relative to Recombinant Factor VIIa On-Demand.

Mehta DA, Oladapo AO, Epstein JD, Novack AR, Neufeld EJ, Hay JW.

J Manag Care Spec Pharm. 2016 Feb;22(2):149-57. doi: 10.18553/jmcp.2016.22.2.149.


Center-Based Quality Initiative Targets Youth Preparedness for Medical Independence: HEMO-Milestones Tool in a Comprehensive Hemophilia Clinic Setting.

Croteau SE, Padula M, Quint K, D'Angelo L, Neufeld EJ.

Pediatr Blood Cancer. 2016 Mar;63(3):499-503. doi: 10.1002/pbc.25807. Epub 2015 Oct 23.


Guidelines for the Standard Monitoring of Patients With Thalassemia: Report of the Thalassemia Longitudinal Cohort.

Tubman VN, Fung EB, Vogiatzi M, Thompson AA, Rogers ZR, Neufeld EJ, Kwiatkowski JL; Thalassemia Clinical Research Network.

J Pediatr Hematol Oncol. 2015 Apr;37(3):e162-9. doi: 10.1097/MPH.0000000000000307.


Sports Participation in Children and Adolescents with Immune Thrombocytopenia (ITP).

Kumar M, Lambert MP, Breakey V, Buchanan GR, Neier M, Neufeld EJ, Kempert P, Neunert CE, Nottage K, Klaassen RJ; ITP Consortium of North America.

Pediatr Blood Cancer. 2015 Dec;62(12):2223-5. doi: 10.1002/pbc.25644. Epub 2015 Jul 14.


Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP.

Frelinger AL 3rd, Grace RF, Gerrits AJ, Berny-Lang MA, Brown T, Carmichael SL, Neufeld EJ, Michelson AD.

Blood. 2015 Aug 13;126(7):873-9. doi: 10.1182/blood-2015-02-628461. Epub 2015 Jul 2.


Erythrocyte pyruvate kinase deficiency: 2015 status report.

Grace RF, Zanella A, Neufeld EJ, Morton DH, Eber S, Yaish H, Glader B.

Am J Hematol. 2015 Sep;90(9):825-30. doi: 10.1002/ajh.24088. Epub 2015 Aug 14. Review.


Safety update on the use of recombinant activated factor VII in approved indications.

Neufeld EJ, NĂ©grier C, Arkhammar P, Benchikh el Fegoun S, Simonsen MD, Rosholm A, Seremetis S.

Blood Rev. 2015 Jun;29 Suppl 1:S34-41. doi: 10.1016/S0268-960X(15)30006-0. Review.


CSF 5-Methyltetrahydrofolate Serial Monitoring to Guide Treatment of Congenital Folate Malabsorption Due to Proton-Coupled Folate Transporter (PCFT) Deficiency.

Torres A, Newton SA, Crompton B, Borzutzky A, Neufeld EJ, Notarangelo L, Berry GT.

JIMD Rep. 2015;24:91-6. doi: 10.1007/8904_2015_445. Epub 2015 May 26.


Author's response: 'Transition considerations for extended half-life factor products'.

Croteau SE, Neufeld EJ.

Haemophilia. 2015 Sep;21(5):e454-5. doi: 10.1111/hae.12718. Epub 2015 May 4. No abstract available.


Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia.

Morris CR, Kim HY, Klings ES, Wood J, Porter JB, Trachtenberg F, Sweeters N, Olivieri NF, Kwiatkowski JL, Virzi L, Hassell K, Taher A, Neufeld EJ, Thompson AA, Larkin S, Suh JH, Vichinsky EP, Kuypers FA; Thalassemia Clinical Research Network.

Br J Haematol. 2015 Jun;169(6):887-98. doi: 10.1111/bjh.13452. Epub 2015 Apr 24.


Transition considerations for extended half-life factor products.

Croteau SE, Neufeld EJ.

Haemophilia. 2015 May;21(3):285-8. doi: 10.1111/hae.12683. Epub 2015 Apr 9. No abstract available.


Liver MRI is more precise than liver biopsy for assessing total body iron balance: a comparison of MRI relaxometry with simulated liver biopsy results.

Wood JC, Zhang P, Rienhoff H, Abi-Saab W, Neufeld EJ.

Magn Reson Imaging. 2015 Jul;33(6):761-7. doi: 10.1016/j.mri.2015.02.016. Epub 2015 Feb 20.


Pediatric heparin-induced thrombocytopenia: prevalence, thrombotic risk, and application of the 4Ts scoring system.

Obeng EA, Harney KM, Moniz T, Arnold A, Neufeld EJ, Trenor CC 3rd.

J Pediatr. 2015 Jan;166(1):144-50. doi: 10.1016/j.jpeds.2014.09.017. Epub 2014 Oct 14.


Correlation between dispensed and prescribed doses of factor products for bleeding disorders: can a small, centre-based pharmacy hit the mark?

Croteau SE, Saxena K, Neufeld EJ.

Haemophilia. 2015 Mar;21(2):190-5. doi: 10.1111/hae.12546. Epub 2014 Oct 14.


Treatment and outcomes of immune cytopenias following solid organ transplant in children.

Schoettler M, Elisofon SA, Kim HB, Blume ED, Rodig N, Boyer D, Neufeld EJ, Grace RF.

Pediatr Blood Cancer. 2014 Oct 12. doi: 10.1002/pbc.25215. [Epub ahead of print]


Impact of acute bleeding on daily activities of patients with congenital hemophilia with inhibitors and their caregivers and families: observations from the Dosing Observational Study in Hemophilia (DOSE).

Recht M, Neufeld EJ, Sharma VR, Solem CT, Pickard AS, Gut RZ, Cooper DL.

Value Health. 2014 Sep;17(6):744-8. doi: 10.1016/j.jval.2014.07.003. Epub 2014 Aug 14.


Rituximab for treatment of inhibitors in haemophilia A. A Phase II study.

Leissinger C, Josephson CD, Granger S, Konkle BA, Kruse-Jarres R, Ragni MV, Journeycake JM, Valentino L, Key NS, Gill JC, McCrae KR, Neufeld EJ, Manno C, Raffini L, Saxena K, Torres M, Marder V, Bennett CM, Assmann SF.

Thromb Haemost. 2014 Sep 2;112(3):445-58. doi: 10.1160/TH14-01-0078. Epub 2014 Jun 12.


Relationship among chelator adherence, change in chelators, and quality of life in thalassemia.

Trachtenberg FL, Gerstenberger E, Xu Y, Mednick L, Sobota A, Ware H, Thompson AA, Neufeld EJ, Yamashita R; Thalassemia Clinical Research Network.

Qual Life Res. 2014 Oct;23(8):2277-88. doi: 10.1007/s11136-014-0671-2. Epub 2014 Mar 30.


The use of erythropoietin-stimulating agents versus supportive care in newborns with hereditary spherocytosis: a single centre's experience.

Morrison JF, Neufeld EJ, Grace RF.

Eur J Haematol. 2014 Aug;93(2):161-4. doi: 10.1111/ejh.12321. Epub 2014 Apr 16.


MRI guided iron assessment and oral chelator use improve iron status in thalassemia major patients.

Nichols-Vinueza DX, White MT, Powell AJ, Banka P, Neufeld EJ.

Am J Hematol. 2014 Jul;89(7):684-8. doi: 10.1002/ajh.23715. Epub 2014 Apr 10.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk